Associate Professor Thomas Oxley MBBS BMedSc FRACP PhD is a vascular and interventional neurologist and world expert in endovascular bionics. He is founding CEO of Synchron, Inc; Instructor, Attending, and Director of Innovation Strategy in the Department of Neurosurgery, Mount Sinai Hospital; and Laboratory Head of the Vascular Bionics Laboratory, University of Melbourne, Australia.Dr Oxley has performed over 1400 endovascular neurosurgical procedures at Mount Sinai Hospital, including cerebral angiography, aneurysm coiling and clot retrievals in acute stroke.
He completed both internal medicine and neurology residency in 2013 at the Royal Melbourne and Alfred Hospitals, Melbourne, Australia. In 2015 he competed a stroke fellowship at the Royal Melbourne Hospital, and was an investigator in the EXTEND-IA trial that demonstrated the paradigm-shifting efficacy of mechanical thrombectomy in the treatment of stroke and published in the New England Journal of Medicine. Dr Oxley completed his PhD in neural engineering in 2016 at the University of Melbourne. Since commencing his PhD he raised $12 million dollars in funding from US and Australian governments, forming a lab for the development of a novel stent electrode (stentrode) neural interface. This included substantial funding from the US defense organization DARPA. In February 2016 the breakout scientific report of the technology was published in Nature Biotechnology (IF 41). A subsequent paper was recently published in Nature Biomedical Engineering demonstrating the feasibility of endovascular brain stimulation. His research laboratory at the University of Melbourne currently includes three post-docs and two research engineers. He has supervised 3 PhD students and 20 honors students. The lab collaborates across 16 departments including medicine, neurology, neurosurgery, engineering, physics and pathology. Dr Oxley has published 60 internationally peer reviewed articles that have accumulated 3478 citations, with 13 as first or last author and with an H Index of 11. Since 2012 Dr Oxley has founded three companies and raised a total of $7.5M in private capital investment. He is the founding CEO of Synchron. Based in Silicon Valley, Synchron is an innovative medical device company focused on the development of minimally invasive neural interface technology and is developing the world’s first endovascular electrode array, the StentrodeTM. The company is working towards a first-in-human clinical trial of a pioneering minimally invasive brain-computer interface Stentrode technology for the direct thought-control of operating systems and a suite of assistive technology applications for patients with paralysis. The Stentrode technology has achieved widespread international media attention including an endorsement by the President of The United States, Barack Obama and being invited to conduct a TEDx talk. He is also the founder of VascuLab: Australia’s first dedicated education and research angiography suite, and premier preclinical research facility for which he secured $3M in capital financing.In 2018 Dr Oxley received the Advance Global Australia Award in Life Sciences, the UNESCO Netexplo award for Innovation, and the Congress of Neurological Surgeons 2018 Innovator of the Year.
Find out more about Thomas Oxley's experience
Thomas Oxley's highlights
FEATURED Journal article
Minimally invasive endovascular stent-electrode array for high-fidelity, chronic recordings of cortical neural activity
Read moreThomas Oxley's selected work
Projects
Displaying the 24 most recent projects by Thomas Oxley.
Project Types
17
Research Grant
7
Research Contracts
Scholarly Works
Displaying the 61 most recent scholarly works by Thomas Oxley.
News
Displaying the 3 most recent news articles by Thomas Oxley.
Honours, Awards and Fellowships
Credentials
Positions
David Bickart Clinical Principal Research Fship
Medicine - Royal Melbourne Hospital
Member
American Society for Neuroradiologists
Member
American Academy of Neurology
Member
American Association of Neurological Surgeons
Member
American Society for Experimental NeuroTherapeutics
Member
Australian and New Zealand Society of Neuroradiology (ANZSNR)
Member
Stroke Society of Australia
Member
Society for Vascular and Interventional Neurology
Member
Australian New Zealand College of Neurologists
Member
Royal Australian College of Physicians
Education
Bachelor of Medical Science
Monash University
Bachelor of Medicine/Bachelor of Surgery
Monash University